Automated Cell Counters Market Research Report Information By Product Type (Fluorescence Image-based Cell Counter, Flow Cytometer and Coulter Counter), By Application (Blood Cells, Cell lines, Microbial cells and Others), By End-use (Pharmaceutical & Biotechnology Companies, Hospitals, Diagnostic Laboratories, Research Institutes and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2034

Automated Cell Counters Market Overview

As per MRFR analysis, the Automated Cell Counters Market Size was estimated at 6.77 (USD Billion) in 2024. The Automated Cell Counters Market Industry is expected to grow from 7.16 (USD Billion) in 2025 to 11.9 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.80% during the forecast period (2025 - 2034). 

Rising incidence of chronic diseases, increased research activities, point-of-care testing (POCT), growing awareness of preventive healthcare, emerging markets, COVID-19 pandemic, customization and integration, are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

In February 2024, Science Foundation Ireland awarded Prof. Sakis Mantalaris €4.88m, and with this, he will be leading a group that will research new strategies in the biomanufacturing of cellular therapeutics.

My Green Lab awarded an ACT Label for the first time to DeNovix CellDrop. As a result, the first cell counter certified by My Green Lab is now in circulation. The label serves as a measure of the environmental footprint of laboratory equipment. It is meant to assist researchers, healthcare leaders, and scientists in making informed decisions that focus on sustainability with regard to water, energy, packaging, manufacturing, and product content, among others.

Since October 2023, My Green Lab has awarded DeNovix CellDrop Automatic Cell Counter an ACT Label certification, which is a first for the company's automated cell counters.

For example, in January 2023, Axion BioSystems came up with the Omni Pro 12, which is directed to serve a wide range of users and incorporates automated functionalities for live cell imaging.

In January 2023, Thermo Fishers introduced their Big Foot cell sorter to the Indian market. It has a user-friendly interface and is capable of sorting and analyzing cells in record time – faster than any other sorter on the market.

Automated Cell Counters Market Trends

• Rising incidence of chronic diseases is driving the market growth

One of the main factors propelling the market for automated cell counts is the rise in the prevalence of chronic diseases. Cancer, diabetes, cardiovascular disease, autoimmune disorders, and respiratory illnesses are examples of chronic diseases, which are distinguished by their protracted nature and frequently disabling effects. 

The need for precise, effective, and quick diagnostic technologies, like automated cell counters, has grown dramatically as these illnesses become more widespread worldwide.

To monitor illness progression, therapy effectiveness, and patient health in general for chronic diseases, regular monitoring is frequently necessary. By delivering quick and accurate assessments of blood cell counts, hemoglobin levels, and other hematological parameters, automated cell counters serve a crucial role in this respect. 

This improves the quality of care for patients with chronic diseases by assisting healthcare practitioners in making knowledgeable decisions and changing treatment programs as necessary.

Improved patient outcomes and less strain on healthcare systems may result from early diagnosis of chronic diseases. Automated cell counters make it possible to detect irregular blood cell counts early on, which can be a sign of more serious health problems. Early disease detection enables prompt treatment, which may stop or delay the progression of the disease and ultimately lower treatment expenses.

The COVID-19 pandemic highlighted the value of diagnostic methods in handling medical emergencies. Despite not being a chronic condition, COVID-19 highlighted the crucial role that automated cell counters play in evaluating patients' immunological responses, tracking the severity of the disease, and supporting therapeutic decision-making. Greater investments and demand for diagnostic technology have resulted from this greater knowledge of these tools. Thus, driving the automated cell counters market revenue.

Automated Cell Counters Market Segment Insights

Automated cell counters Product Type Insights

The automated cell counters market segmentation, based on product type, includes fluorescence image-based cell counter, flow cytometer and coulter counter. The coulter counter segment dominated the market in 2022. Coulter counters are recognized for their exceptional accuracy and precision when it comes to cell counting and sizing. 

They use the electrical impedance theory to calculate the volume of each cell as it passes through a microscopic hole. This accuracy is crucial since numerous applications, including clinical diagnosis and research, call for precise cell measurements.

Automated cell counters Application Insights

The automated cell counters market segmentation, based on Application, includes blood cells, cell lines, microbial cells and others. The blood cells segment dominated the market in 2022. Anemia, leukemia, lymphoma, and thrombocytopenia are among the hematological conditions that are on the rise worldwide. 

Blood cell counts are frequently necessary for these disorders to track the development of the disease, assess the effectiveness of treatment, and identify relapses. Automated cell counts are essential for controlling hematological illnesses because they produce accurate data quickly.

Figure 1: Automated Cell Counters Market, by Application, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Automated cell counters End-use Insights

The automated cell counters market segmentation, based on end-use, includes pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, research institutes and others. The hospitals category generated the most income in 2022. This is because automated cell counters are in high demand in clinical laboratories for blood analysis. Blood cells must be counted and analyzed by automated cell counters in order to diagnose and treat a range of blood illnesses.

Automated cell counters Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Automated Cell Counters Market dominated this market in 2022 (45.80%). North America is the world leader in biomedical research and development. The region is home to a large number of pharmaceutical enterprises, biotech companies, and academic research centers for drug discovery services, clinical trials, and fundamental research. 

This ongoing research activity fuels the demand for better cell counting machinery. Further, the U.S. Automated cell counters market held the largest market share, and the Canada Automated cell counters market was the fastest growing market in the North America region.

Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: AUTOMATED CELL COUNTERS MARKET SHARE BY REGION 2022 (USD Billion)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe Automated cell counters market accounts for the second-largest market share. Public health projects focused at disease prevention and early detection are frequently started by European governments and healthcare institutions. These initiatives can include screenings that use computerized cell counters to find those at risk for different illnesses. 

Further, the German Automated cell counters market held the largest market share, and the UK Automated cell counters market was the fastest growing market in the European region.

The Asia-Pacific Automated Cell Counters Market is expected to grow at the fastest CAGR from 2023 to 2032. Both densely populated urban areas and isolated rural areas make up Asia Pacific's enormous and diversified population. In order to meet a wide range of medical demands, the sheer size of the population generates a significant demand for healthcare services, including diagnostic equipment like automated cell counters. 

Moreover, China’s automated cell counters market held the largest market share, and the Indian Automated cell counters market was the fastest growing market in the Asia-Pacific region.

Automated Cell Counters Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the automated cell counters market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. 

To expand and survive in a more competitive and rising market climate, automated cell counters industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the automated cell counters industry to benefit clients and increase the market sector. In recent years, the automated cell counters industry has offered some of the most significant advantages to medicine. 

Major players in the Automated cell counters market, including Eppendorf, Thermo Fischer Scientific, Countstar Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Chemometec A/S, ALIGNEDGENETICS, Beckman Coulter, Inc. (Danaher), Nanoentek, Olympus Corporation, MERCK KGaA, Sysmex Corporation, Agilent Technologies, Inc., Abbott, Nexcelom Bioscience LLC and others, are attempting to increase market demand by investing in research and development operations.

Thermo Fisher Scientific Inc. (Thermo Fisher) delivers medical equipment, analytical instruments, reagents and consumables, software, and services to satisfy the demands of challenging analytical challenges in research, diagnostics, and clinical laboratories. It offers solutions for cellular biology, synthetic biology, and flow cytometry. Mass spectrometry, genetic sequencing, electron microscopy, protein, and molecular biology research equipment are just a few of the many products that the company sells. 

The company offers services to companies in the environmental, industrial quality, and process control sectors, as well as to academic and research institutes, governmental organizations, pharmaceutical and biotech companies, clinical diagnostic laboratories, and environmental companies. It provides its products and services through its direct sales force, online sales, and third-party distributors across the Americas, Asia-Pacific, and Europe. The headquarters of Thermo Fisher are located in Waltham, Massachusetts, in the US.

Abbott Laboratories (Abbott) discovers, develops, manufactures, and sells a wide range of healthcare products, including branded generic drugs, diagnostic devices, and infant, child, and adult nutritional supplements. Additionally, the company sells a variety of medical devices, including those for heart failure, neuromodulation, electrophysiology, rhythm management, and vascular and structural cardiac devices. 

Additionally, the company offers nutritional products, minerals, and dietary supplements. It has production facilities all around the world and R&D facilities in the US, China, Colombia, India, Singapore, Spain, and the UK. Africa, the Middle East, Latin America, North America, and the Asia-Pacific area are among the regions where the firm sells its products. Abbott is based in Abbott Park, Illinois, a city in the US.

Key companies in the automated cell counters market include

• Eppendorf
• Thermo Fischer Scientific
• Countstar, Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd
• Chemometec A/S
• ALIGNEDGENETICS
• Beckman Coulter, Inc. (Danaher)
• Nanoentek
• Olympus Corporation
• MERCK KGaA
• Sysmex Corporation
• Agilent Technologies, Inc.
• Abbott
• Nexcelom Bioscience LLC

Automated Cell Counters Market Industry Developments

• Q2 2024: Beckman Coulter Life Sciences Launches New AQUIOS STEM System for Automated Stem Cell Analysis Beckman Coulter Life Sciences announced the launch of its AQUIOS STEM System, an automated cell counter designed for stem cell enumeration in clinical laboratories, aiming to streamline and standardize stem cell analysis workflows.
• Q2 2024: Sysmex Launches Next-Generation Automated Hematology Analyzer XN-1000V Sysmex Corporation introduced the XN-1000V, a new automated hematology analyzer with enhanced cell counting and analysis capabilities, targeting improved efficiency and accuracy in clinical diagnostics.
• Q2 2024: ChemoMetec Announces Opening of New Production Facility in Denmark ChemoMetec, a manufacturer of automated cell counters, opened a new production facility in Denmark to expand manufacturing capacity and meet growing global demand for its cell counting instruments.
• Q3 2024: NanoCellect Biomedical Announces Strategic Partnership with Thermo Fisher Scientific NanoCellect Biomedical entered a strategic partnership with Thermo Fisher Scientific to integrate NanoCellect’s automated cell sorting and counting technology into Thermo Fisher’s cell analysis workflows.
• Q3 2024: Bio-Rad Laboratories Launches TC20e Automated Cell Counter Bio-Rad Laboratories launched the TC20e Automated Cell Counter, featuring enhanced image analysis and data connectivity for improved cell counting accuracy in research and clinical laboratories.
• Q3 2024: Nexcelom Bioscience Receives CE Mark for Cellaca MX High-Throughput Automated Cell Counter Nexcelom Bioscience received CE Mark approval for its Cellaca MX High-Throughput Automated Cell Counter, enabling commercialization in the European market for clinical and research applications.
• Q4 2024: Agilent Technologies Acquires Cell Analysis Company BioVision Technologies Agilent Technologies completed the acquisition of BioVision Technologies, a developer of automated cell counting and viability analysis instruments, to expand its cell analysis portfolio.
• Q4 2024: Thermo Fisher Scientific Launches Invitrogen Countess 4 Automated Cell Counter Thermo Fisher Scientific launched the Invitrogen Countess 4 Automated Cell Counter, offering advanced fluorescence and brightfield imaging for rapid and accurate cell counting.
• Q1 2025: Beckman Coulter Life Sciences Announces FDA 510(k) Clearance for AQUIOS STEM System Beckman Coulter Life Sciences received FDA 510(k) clearance for its AQUIOS STEM System, allowing clinical laboratories in the United States to use the automated cell counter for stem cell enumeration.
• Q1 2025: ChemoMetec Appoints New Chief Executive Officer ChemoMetec announced the appointment of a new Chief Executive Officer to lead the company’s global expansion and innovation in automated cell counting technologies.
• Q2 2025: NanoCellect Biomedical Raises $30 Million in Series C Funding NanoCellect Biomedical secured $30 million in Series C funding to accelerate the development and commercialization of its automated cell sorting and counting platforms.
• Q2 2025: Sysmex Corporation Opens New R&D Center Focused on Automated Cell Analysis Sysmex Corporation opened a new research and development center dedicated to advancing automated cell analysis technologies, including next-generation cell counters.

Automated Cell Counters Market Segmentation

Automated Cell Counters Product Type Outlook

• Fluorescence image-based cell counter
• Flow cytometer
• Coulter counter

Automated Cell Counters Application Outlook

• Blood Cells
• Cell lines
• Microbial cells
• Others

Automated Cell Counters End-use Outlook

• Pharmaceutical & biotechnology companies
• Hospitals
• Diagnostic laboratories
• Research institutes
• Others

Automated Cell Counters Regional Outlook

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• Rest of the World
  • Middle East
  • Africa
  • Latin America

Report Attribute/Metric	Details
Market Size 2024	6.77 (USD Billion)
Market Size 2025	7.16 (USD Billion)
Market Size 2034	11.90 (USD Billion)
Compound Annual Growth Rate (CAGR)	5.80 % (2025 - 2034)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2034
Historical Data	2020 - 2024
Report Coverage	Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered	Product Type, Application, End-use, and Region
Geographies Covered	North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered	The U.S., Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled	Eppendorf, Thermo Fischer Scientific, Countstar Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Chemometec A/S, ALIGNEDGENETICS, Beckman Coulter, Inc. (Danaher), Nanoentek, Olympus Corporation, MERCK KGaA, Sysmex Corporation, Agilent Technologies, Inc., Abbott, Nexcelom Bioscience LLC
Key Market Opportunities	Government Initiatives and Regulations.
Key Market Dynamics	Cost Efficiency.